JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins China >> Eurofins Pharma China >> About us

About us

Sidebar Image

The Evolution of Eurofins Central Laboratory in China

As part of the BioPharma Services, Laboratory Testing division, Eurofins Central Laboratory has amassed more than 25 years’ experience. Our clients benefit from the fact that we are part of one of the world’s leading lab organizations. This means they will enjoy end-to-end testing solutions, free from the worry of coordinating multiple vendors. Our testing capabilities are unsurpassed and we are setting new standards with our GCLP/GLP capabilities embedded within the Central Lab.

Eurofins started offering central laboratory services in China back in 2003 and its own Central Laboratory facility was established in May 2008. This addition to the global harmonized network makes Eurofins Central Laboratory one of the top global central laboratory operators in the world, with a total of 4 wholly-owned laboratories in United States, the Netherlands, Singapore and China. With these laboratories, Eurofins Global Central Laboratory can now offer customers a bespoke package of the highest quality central laboratory services worldwide.

The first clinical testing site of Eurofins Central Laboratory commenced its operations in Suzhou and earned its NGSP Level 1 certification in June 2008 and CAP accreditation in May 2009 respectively. The Central Laboratory facility relocated from Suzhou to Shanghai in May 2010 in response to the rapid increase in clinical trials being conducted in the country and the need to meet the special (mainly regulatory) requirements the industry faces in running clinical trials in China.

Eurofins is one of the very few international companies to have established a fully-owned and managed Central Laboratory to serve its customers in China.


The Eurofins History

In 1987, Dr. Gilles Martin created Eurofins Scientific as a high-tech university spin-off to offer the SNIF-NMR® technology to a broad audience. Originally developed to detect the chaptalization of French wines, the technology could now authenticate the origin and purity of a large number of food products including fruit juices and sugar-containing products such as honey, jam, alcoholic beverages, flavors and more recently to non-food products such as cosmetics, chemicals and pharmaceuticals.

Over the next years, Eurofins progressed from a small operation in Nantes with little more than a dozen employees to a leading international life sciences company with a total 2019 annual revenue of EUR 4.56 billion, about 47,000 staff in more than 800 laboratories across 50 countries in North America, South America, Europe and Asia-Pacific. Today, Eurofins Scientific performs over 400 million tests every year providing testing services to three distinct industries, BioPharma, Food and Environment and offers a portfolio of over 200,000 analytical methods.